A macrophage-specific synthetic promoter for therapeutic application of adiponectin

Gene Therapy

Volumn 21, Issue 4, 2014, Pages 353-362

  Kang, W S ^a,b   Kwon, J S ^a   Kim, H B ^a   Jeong, H Y ^a   Kang, H J ^a   Jeong, M H ^a   Cho, J G ^a   Park, J C ^a   Kim, Y S ^a   Ahn, Y ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

atherosclerosis; foam cell; Macrophage specific promoter

Indexed keywords

ADIPONECTIN; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FOAM CELL; GENE OVEREXPRESSION; HELA CELL; LENTIVIRINAE; LIPID STORAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; GENE THERAPY; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

LENTIVIRUS; MUS;

ADIPONECTIN; ANIMALS; ATHEROSCLEROSIS; FOAM CELLS; GENETIC THERAPY; HELA CELLS; HUMANS; LENTIVIRUS; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC;

EID: 84897577194     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.3     Document Type: Article

References (28)

1. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008; 18: 228-232.
2. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 2005; 25: 658-670.
3. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010; 328: 1689-1693.
4. Johnson JL, Newby AC. Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol 2009; 20: 370-378.
5. Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, Johnstone SR et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 2010; 107: 737-746.
6. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394: 894-897.
7. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2: 275-281.
8. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008; 117: 1649-1657.
9. Ishiguro H, Yoshida H, Major AS, Zhu T, Babaev VR, Linton MF et al. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J Biol Chem 2001; 276: 36 742-36 748.
10. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L et al. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003; 107: 2726-2732.
11. Brenner S, Malech HL. Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy. Biochim Biophys Acta 2003; 1640: 1-24.
12. Li AC, Guidez FR, Collier JG, Glass CK. The macrosialin promoter directs high levels of transcriptional activity in macrophages dependent on combinatorial interactions between PU. 1 and c-Jun. J Biol Chem 1998; 273: 5389-5399.
13. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, Glass CK. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci 1995; 92: 5391-5395.
14. He W, Qiang M, Ma W, Valente AJ, Quinones MP, Wang W et al. Development of a synthetic promoter for macrophage gene therapy. Hum Gene Ther 2006; 17: 949-959.
15. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008; 114: 361-374.
16. Trujillo M, Scherer P. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-175.
17. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-2971.
18. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770.
19. Hara S, Shike T, Takasu N, Mizui T. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arterioscler Thromb Vasc Biol 1997; 17: 1258-1266.
20. Turunen P, Jalkanen J, Heikura T, Puhakka H, Karppi J, Nyyssönen K et al. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro. J Lipid Res 2004; 45: 1633-1639.
21. Yla-Herttuala S, Raty JK, Lesch HP, Wirth T. Improving safety of gene therapy. Curr Drug Saf 2008; 3: 46-53.
22. Levin MC, Lidberg U, Jirholt P, Adiels M, Wramstedt A, Gustafsson K et al. Evaluation of macrophage-specific promoters using lentiviral delivery in mice. Gene Therapy 2012; 19: 1041-1047.
23. Li S-L, Valente AJ, Zhao S-J, Clark RA. PU. 1 is essential for p47 phox promoter activity in myeloid cells. J Biol Chem 1997; 272: 17 802-17 809.
24. Li S-L, Schlegel W, Valente AJ, Clark RA. Critical flanking sequences of PU. 1 binding sites in myeloid-specific promoters. J Biol Chem 1999; 274: 32 453-32 460.
25. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003; 46: 1543-1549.
26. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45 021-45 026.
27. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
28. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol 2009; 297: H1535-H1543.